South African health authorities will soon know the effectiveness of a second dose of the Johnson & Johnson Covid-19 vaccine against the Omicron variant.

This, according to professor Glenda Gray, from the South African Medical Research Council.

Gray says healthcare workers who received one dose of the J&J injection, and who picked up breakthrough infections, developed only mild forms of the disease.

Gray says about 218,000 healthcare workers have already gotten a second dose of the J&J injection.

Read the full report here.

Related articles:

The South African-born philanthropist & scientist, Patrick Soon-Shiong says the newly-launched cancer and Covid-19 vaccine initiative will significantly boost South Africa’s capabilities to manufacture its own vaccines.

He launched the initiative late last week and says it will entail a partnership with the Council for Scientific and Industrial Research, the South African Medical Research Council and several South African Universities.

Soon-Shiong says the agreement will enhance the transfer of manufacturing technology for Covid-19 and cancer vaccines.

Follow the full briefing here and read more here.

Related articles: